Original news and analysis on international IP policy
A new report from Public Citizen, the US-based consumer rights advocacy group, shows that the 20 largest pharmaceutical corporations are spending significantly less on research and development of new medicines than they are making in profits.
Establishing a work programme on geographical indications at the World Intellectual Property Organization last week proved elusive. A tentative text and time frame by the chair of the committee on trademark and geographical indications (GIs) issued on the last day of the committee did not meet the approval of some member states. The committee did agree on a set of tasks for the WIPO secretariat on the protection of country names against registration as trademarks, and on the protection of new technological designs, such as icons and type fonts.
The Internet of Things (IoT), which will connect billions of devices in coming years, may offer incredible opportunities for businesses and consumers but it also raises significant intellectual property issues, IP lawyers, mobile operators and others say. One key question is whether patenting and licensing strategies will have to change to adapt to the myriad standards being developed and patents being sought for IoT products and services, and for the coming rollout of 5G technologies.
A new industry report shows that the average prices for orphan drugs are increasing and are projected to comprise more than 20 percent of the patented pharmaceutical sales market by 2022.
The French Ministry of Social Affairs and Health announced today that the ministry has negotiated with pharmaceutical company Gilead to bring down the prices of hepatitis C medicines.
Legislation authorising the president to appoint the Register of Copyright in the United States Copyright Office is working its way through Congress. The “Register of Copyrights Selection and Accountability Act” garnered strong bipartisan support in the House of Representatives Judiciary…
Concerns continue to grow among civil society about provisions in a major trade agreement in the Asian region. Of specific worry is the intellectual property chapter containing in particular a data exclusivity clause, and the linkage between the investment chapter and the IP chapter.
A partnership of government agencies and organisations in the United States and United Kingdom have announced an investment of up to US$48 million into the development of new antibiotics and products to fight antibiotic resistant bacteria, with the aim of having two new antibiotics in human trials in the next five years.
The World Trade Organization has issued a call to hire a legal analyst specialised on intellectual property law, including the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
A range of civil society organisations today issued a letter to European Union leadership urging support for a World Health Organization resolution that mandates a feasibility study on a fund for cancer research and development that delinks R&D costs from the price of health technologies.
The director of the United States Patent and Trademark Office (USPTO), Michelle Lee, today resurfaced after weeks of silence, speaking after the trilateral meeting of the US, European and Japan patent offices. Among her remarks was praise for Latin American countries for joining the Patent Prosecution Highway, which she said has already resulted in much faster patents in the region.
A tentative way to continue conversing about geographical indications (GIs) at the World Intellectual Property Organization committee on trademarks and GIs was tabled by the committee chair today. The suggested approach includes a questionnaire to member states on the different ways GIs are addressed by national and regional systems. Meanwhile, a potential design law treaty was pushed off to the next WIPO General Assembly, held in autumn.